Đăng nhập/ Đăng ký

Novo Nordisk shares fell, wiping away the last gains Wegovy's launch had brought, after the drugmaker said its next-generation obesity drug CagriSema underperformed Eli Lilly's tirzepatide in a trial

23/02 22:15
Tăng giá
Bearish

Cập nhật trực tiếp

Tin tức xu hướng